Arch Dis Child Educ Pract Ed doi:10.1136/archdischild-2012-303327
  • Interpretations

How to use...  neonatal TORCH testing

  1. Enrico Lopriore3
  1. 1Department of Paediatrics, Juliana Children's Hospital, HAGA Hospital, The Hague, The Netherlands
  2. 2Department of Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands
  3. 3Division of Neonatology, Department of Paediatrics, Leiden University Medical Centre, Leiden, The Netherlands
  1. Correspondence to Dr Enrico Lopriore, Division of Neonatology, Department of Paediatrics, J6-S, Leiden University Medical Centre, PO Box 9600, Leiden 2300 RC, The Netherlands; e.lopriore{at}
  • Received 6 November 2012
  • Revised 1 February 2013
  • Accepted 6 February 2013
  • Published Online First 7 March 2013


Toxoplasma gondii, rubella, cytomegalovirus and herpes simplex virus have in common that they can cause congenital (TORCH) infection, leading to fetal and neonatal morbidity and mortality. During the last decades, TORCH screening, which is generally considered to be single serum testing, has been increasingly used inappropriately and questions have been raised concerning the indications and cost-effectiveness of TORCH testing. The problems of TORCH screening lie in requesting the screening for the wrong indications, wrong interpretation of the single serum results and in case there is a good indication for diagnosis of congenital infection, sending in the wrong materials. This review provides an overview of the pathogenesis, epidemiology and clinical consequences of congenital TORCH infections and discusses the indications for, and interpretation of, TORCH screens.

Register for free content

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC Education & Practice.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article